Cellectis (CLLS) Accumulated Expenses (2016 - 2024)

Cellectis' Accumulated Expenses history runs 7 years deep, the most recent figure standing at $8.8 million for Q4 2024.

• In Q4 2024, Accumulated Expenses fell 5.74% year-over-year to $8.8 million; the TTM figure through Dec 2024 stood at $8.8 million (down 5.74% YoY), while the FY2024 annual figure was $8.8 million, down 5.74% from the prior year.
• Accumulated Expenses for Q4 2024 stood at $8.8 million, up from $7.0 million in the prior quarter.
• The five-year high for Accumulated Expenses was $9.4 million in Q4 2022, with the low at $339000.0 in Q4 2021.
• The 4-year median for Accumulated Expenses is $7.9 million (2024), against an average of $5.9 million.
• The sharpest annual moves came in 2022 and 2024: Accumulated Expenses soared 2679.06% in 2022, then retreated 5.74% in 2024.
• Cellectis' Accumulated Expenses stood at $339000.0 in 2021, then jumped by 2679.06% to $9.4 million in 2022, then dropped by 0.56% to $9.4 million in 2023, then retreated by 5.74% to $8.8 million in 2024.
• Business Quant data shows CLLS's Accumulated Expenses at $8.8 million in Q4 2024, $7.0 million in Q2 2024, and $9.4 million in Q4 2023.